Table of Contents

NamItAll drives the adoption of New Approach Methodologies (NAM) by providing education, curated research, career guidance, and profiles of scientists, organizations, and companies leading biomedical and disruptive innovation.

What is NAM?

New Approach Methodologies (NAM) are innovative, non-animal testing strategies that use advanced technologies (eg cell-based assays, organoids, computational models, organ-on-a-chip) to improve the accuracy, efficiency, and ethics of biomedical research, toxicology, and drug development.

Fields of Impact

These include various areas such as:

• Organ-on-a-Chip: Using microengineered devices to model human physiology and test responses to drugs or toxins.
• Bioprinting: 3D printing of living cells and tissues to create functional human tissue models for research.
• Organoids: Using 3D miniature organ models derived from stem cells to study human biology and disease.
• AI: Leveraging artificial intelligence and machine learning to analyze complex biological data and predict outcomes.
• Disease Modeling: Creating human-relevant models of diseases to study mechanisms and test interventions without animal testing.
• Personalized Medicine: Tailoring medical treatments to individual patients using NAM-based approaches.
• Toxicology: Evaluating chemical safety, risk assessment, and environmental hazards using advanced in vitro and computational models.
• Pharmaceuticals: Accelerating drug development, efficacy testing, and toxicity screening with human-relevant NAM to bring safer treatments to market faster.
• Environmental Science: Assessing the impact of pollutants, chemicals, and other agents on ecosystems and human health without animal testing.